What the Peer-Reviewed Record Establishes
The primary research record in Impact on Endometrial Receptivity and Fecundity is stratified by study design so that meta-analyses and replicated randomised controlled trials (T1–T2) carry greater epistemic weight than observational cohorts (T3–T4) or preclinical laboratory work (T5). Leading graded findings establish the core empirical baseline: [T1] There is no strong consensus or robust evidence from randomized controlled trials that polypectomy routinely increases pregnancy rates in infertile women planning IVF. [31][49] [T2] Intentional endometrial injury (scratching/peeling) in women with recurrent implantation failure (RIF) has shown variable impacts, with some trials reporting no significant increase in success rates compared to diagnostic hysteroscopy alone. [17][35]
Further clinical and mechanistic stratification across the literature demonstrates: [T3] Hysteroscopic polypectomy prior to intrauterine insemination (IUI) significantly increases pregnancy rates in infertile women, achieving a relative risk of 2.1 (95% CI 1.5-2.9) compared to diagnostic hysteroscopy and biopsy. [54] [T3] A significant proportion of infertile women (65%) with endometrial polyps may conceive spontaneously after hysteroscopic resection, even before initiating scheduled IUI cycles. [42][54]
Comparative Evaluation of Levers & Theoretical Models
Within the Tree of Knowledge, this field branches into 3 specialised sub-disciplines: Anatomical and Fluid Dynamic Mechanisms of Implantation Failure (Physical obstruction of sperm or blastocyst transport, altered uterine cavity fluid composition, and localized hyperestrogenism disrupting the window of implantation); Assisted Reproductive Technology Outcomes and Polypectomy Timing (Quantitative effect sizes of hysteroscopic polypectomy on clinical pregnancy, implantation, miscarriage, and live birth rates across IVF, ICSI, and IUI cycles); Co-pathology with Chronic Endometritis and Dysbiosis (Prevalence, immunohistochemical identification (CD138 plasma cells), and inflammatory cytokine cascades (TNF-alpha, IL-6, IL-1beta) in tissue microenvironments adjacent to polyps).
Evolution of the Field, Open Debates & Active Trials
Chronologically, the field evolved through key inflection points: in 2005, First RCT for Polypectomy and IUI Outcomes (Publication of the first prospective randomized study demonstrating that hysteroscopic polypectomy improves pregnancy outcomes in women undergoing intrauterine insemination); in 2021, Meta-analysis Findings on Polypectomy (A meta-analysis concludes no significant difference in pregnancy/live birth outcomes between expectant management and hysteroscopic polypectomy in asymptomatic infertile women); in 2022, Identification of CE as a Major Risk Factor for Polyp Recurrence (Studies established that chronic endometritis, diagnosed via CD138, significantly increases the recurrence risk of endometrial polyps post-polypectomy).
Active scientific debates and unresolved methodological tensions centre on: While some evidence suggests potential benefit in RIF patients, broad consensus on routine polypectomy for IVF remains absent due to the lack of high-quality RCTs. (contradiction) Studies on post-polypectomy timing for embryo transfer provide conflicting results, lacking a clear biological or clinical consensus. (weak evidence)
Open Questions & Priorities for the Next Research Sweep
Methodological priorities and open empirical questions queued for the next research sweep across Impact on Endometrial Receptivity and Fecundity focus on resolving subgroup effect sizes, causal mechanisms, and long-term outcomes:
- Optimal timing for embryo transfer post-polypectomy remains undefined.
- The influence of polyp size and multiplicity on IVF outcomes requires further clarification as current data shows no significant difference.
- Standardized protocols for the treatment of chronic endometritis to prevent polyp recurrence are lacking.